INTRODUCTION
============

Pain in the masticatory muscles is the most prevalent symptom associated with temporomandibular disorders (TMD), being present in 88.7% of the affected population^[@r06]^. Function impairment is also experienced by TMD patients, including reduced chewing ability. Kurita, et al.^[@r13]^ (2001) found a positive correlation between chewing ability and TMJ pain and reduced mouth opening capacity, although no significant association was found for noises and muscle tenderness.

Different types of muscle hyperactivity have been associated with muscle pain, among those bruxism, as well as extensive voluntary repeated maximum contractions, innate weakness in the strength of a muscle accentuated by repeated maximum contractions and continuous use of the muscle^[@r18]^. The overuse of the masticatory muscles has also been associated with changes in the blood supply, suggesting that ischemia may occur during contraction above a given threshold^[@r18]^.

Lobbezoo-Scholte, et al.^[@r14]^ (1993) studied the validity of six tests to discriminate patients from control subjects and found that passive opening measurement and palpation were the most useful for this purpose. Dao, Lund and Lavigne^[@r05]^ (1994) and Gavish, et al.^[@r08]^ (2002) concluded that pain can be either increased, decreased or unaltered when assessed the discriminative power of an experimental chewing test in patients with myofascial pain (MFP). The existence of two different pathologies or different pre-exercise pain levels could explain these different reaction^[@r05]^. Gavish, et al.^[@r08]^ (2002) carried out a similar study, increasing the exercise time and measuring the pain using the Visual Analogue Scale (VAS) over 9 min at rest. They concluded that a strenuous chewing exercise is a potential beneficial tool in the diagnostic process of MFP. In spite of that, the phenomenon of pain reduction in a small percentage of the patients with MFP should be further investigated.

Pressure-pain threshold (PPT) has been extensively used in diagnostic studies^[@r19],[@r23]^of myogenic TMDs as well as in therapeutic studies^[@r15]^, but little is known about the impact of chewing exercises on PPT measurements of symptomatic patients. Farella, et al.^[@r07]^ (2001) evaluated those parameters in 15 healthy women and did not find significant increase of pain intensity during a 40min soft-gum chewing task nor a significant PPT reduction after the test.

Investigators have used some exercises to induce muscle pain, such as tooth grinding^[@r02]^, experimental chewing^[@r05],[@r08]^, electromyographically controlled clenching^[@r02],[@r03]^, and maximal protrusion^[@r19]^. The literature has demonstrated that muscular hyperactivity exerts an important role as an etiological factor in this pain modality, since a symptomatic muscle pain relief has been observed concomitant to reduction in muscular activity^[@r06],[@r17]^.

The purpose of this study was to test whether there are distinct pain responses to chewing exercise among patients with MFP with mild to moderate pain, and verify whether this protocol could be used to distinguish patients with MFP from control subjects.

MATERIAL AND METHODS
====================

Subjects
--------

The MFP group consisted of 29 consecutive Caucasian women (mean age 29.83±8.43 years, ranged from 18 to 49) selected among those seeking for treatment at the Orofacial Pain Clinic of the Bauru School of Dentistry, University of São Paulo, Brazil. Inclusion criteria followed the diagnostic of MFP (Group Ia), according to the Research Diagnostic Criteria (RDC/TMD)^[@r06]^. Patients with more than two absent teeth, history of facial or cervical injury, cervical pain or limited range of motion, active periodontal disease or caries, history of general neurological disturbances cervical and/ or masticatory active trigger points were excluded from the study. The diagnosis of TMJ disorders, according to RDC/TMD^[@r06]^ (diagnostic II) were also an exclusion criterion, although individuals with asymptomatic disc displacement joint (IIa, without pain) concomitant with Ia diagnostic (RDC/TMD^[@r06]^) were allowed to participate. The patients should not have taken any analgesic medication within 24 h prior to the experimental procedure.

The control group was comprised by 15 asymptomatic Caucasian women (means age 25.47±1.23 years, ranged from 20 to 35) recruited at the regular dental clinics of the Bauru School of Dentistry. None of the subjects had any facial pain complaint or underwent TMD treatment 6 months prior to the experiment. except for pain, the inclusion criteria for the control group were the same to the used for the MFP group. All participants granted a written informed consent to participate in the study (126/2004).

Experimental Design
-------------------

All participants filled out the RDC/TMD^[@r06]^ questionnaire and were examined by one of the authors. The digital palpation was carried out with a pressure of 1.0 kgf to the extraoral sites and approximately 0.5 kgf to the intraoral and articular sites, as recommended by the RDC/TMD^[@r06]^. This pressure was previously calibrated using an algometer (Dinamometer model DDK, Kratos equipamentos, Cotia, SP, Brazil ).

Due to evidence of low specificity or palpation bias^[@r09]-[@r11],[@r20],[@r22]^, palpation of the "lateral pterygoid area", though part of the screening evaluation (RDC/TMD^[@r06]^), was replaced by palpation of the deep portion of masseter, in order to maintain the 20 sites proposed in RDC protocol, as documented in previous studies^[@r01],[@r21],[@r23]^.

Following the clinical examination, an experimental chewing exercise was performed, which was modified from Gavish, et al.^[@r08]^ (2002). The test was performed with the same interval time, though with a different chewing material.

During the sessions of the chewing test, the subjects were seated comfortably in a dental chair, in an upright position and with their heads leaning back on the headrest. Before the chewing test (P0), the participants were asked to indicate their pain intensity on a Visual Analog Scale (VAS), which ranged from 0 mm ("no pain") to 100 mm ("the worst imaginable pain"). Each VAS was filled out on a separate piece of paper in order to avoid bias of previous VAS records.

With the aid of an algometer, the PPT of the superficial masseter (body) (M), as well as the anterior (AT), medium (MT) and posterior temporalis (PT) muscle was also established bilaterally before the test (PPT0). With a rate of application of about 0.5 kg/cm^2^/s, the pressure was applied until it became painful. At this point, the participant was instructed to push a hand-held button attached to the algometer, so the amount of pressure was automatically recorded by the device.

After recording the baseline measurements (VAS and PPT), the subjects were instructed to start chewing. They were requested to chew on a stick of chewing gum (Trident^®^, Cadbury, Bauru, SP, Brazil) for 9 min at the preferred side. After that, individuals were instructed to hold their jaws at a rest position (lips together and teeth apart) for additional 9 min, completing the total period test of 18 min.

VAS was recorded again after 3, 6, and 9 min (P3, P6, and P9, respectively) after the beginning of the experiment, and during the rest period at 12, 15 and 18 min (P12, P15, and P18, respectively), while PPT measurements were taken at times 9 (PPT9) and 18 (PPT18).

The Kolmogorov-Smirnov test was used to verify homogeneity in all groups (*P*\<0.05). The student's t test (parametric data) and Mann-Whitney test (non-parametric data, *P*\<0.05) were used to verify statistically significant differences between control and MFP groups regarding VAS and PPT. ANOVA for repeated measures and Tukey's test (parametric data) and Friedman's test followed by the Student- Newman-Keuls test (α=0.05) (non-parametric data) were used to verify intragroup differences in different moments of PPT records. The statistical analysis was performed using the SigmaStat 2.0 software (Jandel Scientific Software, San Jose, CA, USA).

RESULTS
=======

Patients with MFP presented the following values of VAS (present pain: 47.79±22.27 mm; mean pain in the last six months: 50.34±2.03 mm, and maximal pain in the last six months: 67.93±19.34 mm). They had a mean active mouth opening of 45.90±10.95 mm and a mean number of sensitive palpation sites of 8.37±4.73 mm. On the other hand, control group had no pain on the VAS; 45.07±6.55 mm of mean active mouth opening; and a mean number of sensitive palpation sites of 0.40±0.63 mm. The most prominent findings were the differences in VAS pain intensity and in mean number of sensitive palpation sites (p\<0.001). There was no significant difference in active mouth opening (p=0.334).

Chewing test
------------

At P9, patients with MFP reported a mean pain increase of 18.79 mm, while controls had an increase of 3.33 mm in VAS records. None of the patients with MFP reported pain reduction, 7 (24%) reported no change in pain (MFP NCP), and 22 (76%) reported an increase (MFP IncP). Within the MFP IncP patients, the mean increase of pain at P9 was 23.59 mm. However, at P12, two additional patients experienced an increase in pain, elevating the percentage of this subgroup to 82.76% (24 subjects) and reducing the percentage of patients who had no change in pain (MFP NCP) to 17.24% (5 subjects). For the control group, 13 (87%) patients had no change in pain and only 2 subjects (13%) experienced pain increase at P9. Data concerning pain intensity (VAS) and their fluctuation over time in both groups at the different measurement points are presented in [Figure 1](#f01){ref-type="fig"}.

![Pain intensity during the chewing test of patients with myofascial pain (MFP) and control subjects. \* the same number of asterisks indicates no statistically significant differences (p\<0.05) (intragroup analysis). † significant differences between groups at the same intervals time (intergroup analysis)](jaos-19-01-0034-g01){#f01}

When applied a Friedman repeated measures ANOVA on ranks on VAS scores of both groups, no statistical difference was found in the control group along the whole experiment (exercise and rest) ([Figure 1](#f01){ref-type="fig"}). Conversely, the MFP group showed a clear increase on pain intensity from P0 up to P9. From this point, a slight decrease in the intensity levels was revealed, but not enough to recover to pre-exercise levels ([Figure 1](#f01){ref-type="fig"}).

There was no significant difference in initial pain intensity (P0) between MFP NCP and MFP IncP patients. However, a significant difference in pain intensity between these subgroups was found after chewing (*p*=0.002).

Analysis of covariance of pain levels during the chewing experiments yielded the following: a significant main effect for group (MFP vs. control, *P*=0.002) and for time (p\<0.001), but not for activity (chewing or rest). Also a significant interaction between group, activity and time (*p*=0.01) was found. These findings reveal the effect of the chewing activity on the pain level in both groups over time, but do not indicate a significant recovery at rest ([Figure 1](#f01){ref-type="fig"}). In the MFP group, the pain increased 18.79 mm at P9 and recovered to levels above (13.00 mm) the preexercise levels.

PPTs were significantly lower in patients with MFP than in controls at all recording sites and at all the times (PPT0 to PPT18). [Figure 2](#f02){ref-type="fig"} shows PPT fluctuations over periods 0, 9, and 18 min (PPT0, 9, and 18, respectively) of each muscular site of MFP and control group. Data from right and left sides were pooled because PPTs obtained bilaterally in the jaws have been shown to be correlated^[@r15]^. In the control group, statistically significant reductions on PPT9 were observed only in anterior and posterior temporalis. For the MFP group, PPT9 values were significant reduced for all muscle sites. After the rest period (PPT18), however, the PPT values remained significantly lower than the pre-exercise figures (PPT0) ([Figure 2](#f02){ref-type="fig"}).

![Pressure-pain threshold (PPT) during chewing test \[patients with myofascial pain (MFP X control)\]. \* significant difference from PPT0 in the same muscle, for the control group. \*\* significant difference from PPT0 in the same muscle, in the MFP group. MM=superficial masseter body; MT= medium temporalis; AT= anterior temporalis; PT= posterior temporalis](jaos-19-01-0034-g02){#f02}

Among the patients with MFP, 18 (62.07%) started the exercise with VAS pain between 0 and 5 mm (MFP P0=0). In order to evaluate the weight of this variable on the final result, comparisons between MFP P0=0 and those who started with VAS higher than that were made:

Intergroup evaluation: The MFP P0=0 patients showed PPT0 values significantly higher than those who started exercise with EAV greater than 0 (MFP\>0); and similar to pre-exercise PPTs of control group. After chewing, MFP P=0 patients showed PPT9 and PPT18 significantly greater than MFP P0\>0 and significantly lower than the control group for all recording sites.

PPT9: At all muscles sites, but the anterior temporalis, MFP NCP showed PPTs significantly higher than MFP IncP. Moreover, except the MT and PT, MFP NCP showed PPT9 significantly lower than the control group ([Figure 3](#f03){ref-type="fig"}). It means that PPT9 of MFP NCP were in between the control group and MFP IncP.

![Pain during chewing test of patients with myofascial pain who reported a pain increase (MFP IncP), x no change in pain (MFP NCP) an control subjects](jaos-19-01-0034-g03){#f03}

PPT18: After rest (PPT 18), MPF NCP showed PPT values similar to MFP IncP and significantly lower than the control group at all muscle sites but the PT ([Figure 4](#f04){ref-type="fig"}).

![Pressure-pain threshold (PPT) during chewing test \[patients with myofascial pain who reported a pain increase (MFP IncP) x no change in pain (MFP NCP)\]. MM=superficial masseter body; MT= medium temporalis; AT= anterior temporalis; PT= posterior temporalis](jaos-19-01-0034-g04){#f04}

Intragroup evaluation
---------------------

With the exception made for the MT, which PPT9 did not change significantly, all other muscles in both subgroups presented similar PPTs evolution pattern along the whole experiment, i.e., PPT9 significantly lower than PPT0 and PPT18 significantly lower than PPT0 and similar to PPT9 ([Figure 4](#f04){ref-type="fig"}). That means that, regardless of VAS evolution, the MFP group experienced a decrease of PPT after the exercise, and 9 min of rest are not enough to recover it to pre-exercise levels.

The discriminative ability of the test to distinct patients from controls was demonstrated by a sensitivity of 0.76, a specificity of 0.87, a positive likelihood ratio (LR+) of 5.69 (CI95: 1.992--31.012), and a negative likelihood ratio (LR-) of 0.28 (CI95: 0.128--0.515). A pre-test probability of 66% (0.66), post-test probability to LR+ of 0.92 (92%) and to LR- of 0.35 (35%) were also found, while the odds ratio (OR) was 20.37. It means that the risk of a person who report increase in pain to have MFP is 0.92 (92%), while the risk of a person who do not change in pain with this protocol to have MFP is 0.35 (35%). Therefore, the relative risk is 2.62. The Chi-square was 15.590 (p=0.000078).

DISCUSSION
==========

Despite the small sample size, the experimental and control groups clearly demonstrated different responses after the experimental chewing. The increase in pain intensity in the MFP group along the chewing exercise was significantly higher when compared to the healthy controls. This fact highlights ultimate differences in pain behavior upon function between healthy subjects and patients with MFP.

Gavish, et al.^[@r08]^ (2002) and Dao, Lund and Lavigne^[@r05]^ (1994) showed mean pain increases of 28.3 e 32 mm, respectively (values above the smallest detectable difference^[@r12]^). In the present study, this pattern was of 23.59 mm. Differences in the pre-test pain VAS may explain that difference. While the present study obtained mean initial values of VAS of 12.03±18.27 mm (18 patients with preexercise VAS=0), Dao, Lund and Lavigne^[@r05]^ (1994) had 35.2±2.7 mm (all patients with EAV\>0) and Gavish, et al.^[@r08]^ (2002) 25.06±26.42 mm.

The frequency of patients which experienced variations in pain intensity during functional exercise was pointed out by earlier studies, as followed: increase in pain (48.3%^[@r05]^ and 84%^[@r08]^); no change in pain (20%^[@r05]^ and 10%^[@r08]^); and reduction in pain (31.7%^[@r05]^ e 6%^[@r08]^). In the present study, 76% of the sample experienced pain increase, and 24% reported no change. None of the individuals reported decrease in pain intensity. These finding are in accordance to Gavish, et al^[@r08]^ (2002) and could be explained due to similar inclusion criteria, which excluded patients with cervical trigger points and arthralgia. Dao, Lund and Lavigne^[@r05]^ (1994) hypothesized that the reaction to exercise may be related to the pre-exercise pain level, since the patients who presented a decrease in pain had a level of pre-exercise pain significantly higher(55.8±4.0 mm) than those who had an increase in pain (27.5±3.1 mm). Again, the mean low pre-exercise pain level observed in this study could be responsible for the absence of this occurrence. Undoubtedly, this feature limits the comparison with other studies. A more comprehensive sample with patient subgroups for pain intensity (low, mild and high) might be necessary to confirm the hypothesis of Dao, Lund and Lavigne^[@r05]^ (1994). Also, to avoid confounding factors, the present study ruled out individuals with any sign of referred pain due to trigger points, as well as those that had taken any analgesic medication within 24 h prior to the experiment. Thus, a more homogenous sample of patients with MFP with mild (n=18) and moderate (n=11) pain levels was composed.

Among the control subjects, only 2 showed increased VAS after the exercise, while the remaining 13 reported no change in pain intensity. These findings are in agreement with those of Farella, et al.^[@r07]^ (2001), who reported no change on VAS in healthy subjects after 40 min of chewing on a soft gum.

Silva, et al.^[@r19]^ (2005) demonstrated cut-off values of PPT to each of muscular sites evaluated in the present study. They found 1.5, 2.47, 2.75, and 2.77 kgf/cm^2^ to the superficial masseter (belly), and the anterior, middle, and posterior temporalis, respectively, with specificity of 90.8%. In the present study all pre-exercise mean PPTs of patients with MFP were below those cut-off values (1.40, 1.60, 1.85, and 1.94 kgf/cm^2^ respectively). However, mean pre-exercise PPTs of control subjects to anterior and middle temporalis stayed just below them (2.13 and 2.32 kgf, respectively), though significantly above the MFP group.

At chewing completion (PPT9), all PPTs of patients with MFP were lower than baseline (PPT0), whereas the control group showed significant reduction of PPT only for the anterior and posterior temporalis, with subsequent recovery to similar PPT0 levels at PPT18. These findings are in agreement with those of Christensen, et al.^[@r04]^ (1996) and Farella, et al.^[@r07]^ (2001) who gave further evidence that the human jaw muscles in healthy subjects recover quickly after prolonged gum chewing, demonstrating that the amount of masticatory loading did not affect muscle tenderness in healthy subjects.

Based on PPT evolution of the control group, MFP NCP and MFP IncP, it could be assumed that the pain/PPT behavior during the exercise in patients with MFP seems to be associated to the pre-exercise pain (VAS) and PPT levels. Nevertheless, it is not possible to compare these findings with those of Dao, Lund and Lavigne^[@r05]^ (1994) due to differences in pre-exercise pain levels.

After chewing (P9), MFP NCP patients, showed a more similar pattern to MFP IncP than to the control group. Despite of this similarity, MFP NCP patients showed PPT9 values statistically greater than MFP IncP. This fact may be explained by the differences between the PPT0 values, significantly and "almost significantly' greater than those of IncP patients (p=0.012 for PT, 0.057 for MM; and 0.051 for AT). The differences in PPT9 values between MFP NCP and IncP patients could be also due to pre-exercise PPT values. Patients with mild VAS pain tend to present a mild VAS pain reaction on to exercise and those with moderate VAS pain trend do present, also, a moderate reaction to exercise. Similarly, the PPT0 values seem to be the main factor to the tenderness exacerbation during function.

Pain stimulation or exacerbation in patients with MFP due to chewing is well demonstrated as one of the most important characteristics of musculoskeletal pain. McMillan and Blasberbg^[@r15]^ (1994) have described similar findings in subjects with MFP. Farella, et al.^[@r07]^ (2001) described that the exercise-induced pain and fatigue has been related to ischemia and to accumulation of metabolic waste products. Indeed, it has been shown that during activity of the jaw muscles, muscle blood flow may be hampered, probably due to an increased intramuscular pressure and nipping of the vessels entering the muscle. However, Nielsen, et al.^[@r18]^ (1990) demonstrated that subjects with muscle pain in craniomandibular muscles, regardless the location of the pain and the muscle involved, recruit the anterior temporalis and masseter muscles less often and with lower activity.

The sensitization of muscle nociceptors is probably the peripheral mechanism underlying local tenderness and the pain upon function of a pathologically altered muscle, related to the release of endogenous substances, such as prostaglandin and bradykinin. Central mechanisms also contribute for this event in chronic pain patients, as very well documented^[@r16],[@r17]^.

Despite the presence of some patients with MFP who did not change in pain to exercise, this protocol presented an OR value greater than the majority of combined orthopedic tests in a previous study^[@r14]^. Those authors studied the discriminative ability of six orthopedic tests and combinations to distinguish different subtypes of TMD (myogenous and arthrogenous). For this reason, it is not possible make any direct comparison with our OR values.

The sensitivity of this test was higher than the minimal acceptable level (0.75) reported by Widmer, Lund and Feine^[@r24]^ (1990). However, the specificity remained just below the minimum acceptable values of 0.90^[@r24]^. The findings of the present study (LR and OR) indicate an adequate discriminative ability of this protocol to distinguish patients with MFP from healthy controls. However further studies with a more representative sample of patients with MFP with low, moderate and severe intensities of pain are necessary.

CONCLUSIONS
===========

The findings of the present study give further evidence that: 1) There are at least two subtypes of patients with MFP who can be expected to respond differently to experimental chewing, either with an increase in pain or not; 2) Probably because of different reactions to exercise within the MFP group, this protocol showed an adequate discriminative ability; and 3) The pre-exercise pain/PPT levels seem to influence coherently the pain/PPT response to exercise in patients with MFP with mild and moderate pain.
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